Press Releases April 22, 2026 04:30 PM

Full House Resorts Announces First Quarter Earnings Release Date

Full House Resorts schedules Q1 2026 earnings release and conference call.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
FLL

Full House Resorts, a gaming company operating multiple casino properties across the U.S., announced it will release its first quarter 2026 financial results on May 7, 2026, and host a subsequent conference call. The announcement details how investors can access the live webcast and replay of the call and includes a caution about forward-looking statements and associated risks.

Full House Resorts Announces First Quarter Earnings Release Date
FLL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Full House Resorts will report Q1 2026 financial results on May 7, 2026.
  • The company operates gaming properties in multiple states including Illinois, Colorado, Mississippi, Indiana, and Nevada.
  • Investors can access the earnings call live via webcast or phone, with a replay available until May 21, 2026.

LAS VEGAS, April 22, 2026 (GLOBE NEWSWIRE) -- Full House Resorts (NASDAQ: FLL) announced today that it will report its first quarter 2026 financial results on Thursday, May 7, 2026, followed by a conference call at 4:30 p.m. ET (1:30 p.m. PT). Investors can access the live audio webcast from the Company’s website at www.fullhouseresorts.com under the investor relations section. The conference call can also be accessed by dialing (201) 689-8470.

A replay of the conference call will be available shortly after the conclusion of the call through May 21, 2026. To access the replay, please visit www.fullhouseresorts.com. Investors can also access the replay by dialing (412) 317-6671 and using the passcode 13757785.

Forward-looking Statements
This press release may contain statements by Full House Resorts, Inc. that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Additional information concerning potential factors that could affect our financial condition and results of operations is included in the reports we file with the SEC, including, but not limited to, our Form 10-K for the most recently ended fiscal year and our other periodic reports filed with the SEC. We are under no obligation to (and expressly disclaim any such obligation to) update or revise our forward-looking statements as a result of new information, future events or otherwise, except as otherwise required by law. Actual results may differ materially from those indicated in the forward-looking statements.

About Full House Resorts, Inc.
Full House Resorts owns, leases, develops and operates gaming facilities throughout the country. The Company’s properties include American Place in Waukegan, Illinois; Chamonix Casino Hotel and Bronco Billy’s Casino, both in Cripple Creek, Colorado; Silver Slipper Casino and Hotel in Hancock County, Mississippi; Rising Star Casino Resort in Rising Sun, Indiana; and Grand Lodge Casino, located within the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada. For further information, please visit www.fullhouseresorts.com.


Risks

  • Forward-looking statements involve uncertainties and risks that could cause actual results to differ materially, including market volatility and changes in the gaming industry.
  • Economic and regulatory conditions affecting the gaming sector could impact financial performance.
  • Dependence on multiple geographic locations subjects the company to diverse local economic and regulatory risks.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026